Retailer program enrollment and operational milestones for the ActiPatch® experience.
Electrome Corporation today provided an update on the PAINKILLER retailer program. The program continues to add retailer partners across pharmacy, mass retail, and specialty channels, and operational milestones across collateral, sell sheets, and platform integration are on plan.
Retailer onboarding, sell sheet generation, and post purchase platform integration are operating at the cadence the company committed to at launch. Specific retailer names and store counts are disclosed only when partners authorize disclosure.
The Electrome retailer program is the channel through which the FDA cleared pulsed shortwave therapy device behind PAINKILLER reaches consumers on retail pain category shelves. The program supports retailers with merchandising, regulatory compliant marketing language, and a co branded patient experience that connects the in store purchase back to the supporting platform. The program is built around long term partner relationships rather than short term placement, which is why retailer names and store counts are disclosed only when partners authorize disclosure.
Retail matters in the bioelectric pain category because a meaningful share of patients first encounter non opioid options on a pain category shelf rather than in a clinical setting. Meeting those patients where they already shop is part of how the bioelectric category reaches the population that benefits from it. The retailer program is built to do that responsibly, with the regulatory boundaries of the cleared device respected at every step.
Electrome Corporation operates the bioelectric medicine platform behind PAINKILLER, with coordinated channels across direct to consumer, provider, retailer, affiliate, and research relationships. The retailer program is one of those coordinated channels.
Retailer alignment is structured to fit the operational realities of pain category shelf space. Partner onboarding includes the merchandising assets, the staff training material, and the ongoing reorder workflow that retail pain category buyers expect. The Electrome platform supports the partner relationship after the placement with shared visibility into sell through and category fit, so each placement can be evaluated and refined on real evidence.
Retailer program enrollment and operational milestones for the ActiPatch® experience.
More stories
Access is the part of the non opioid story that often gets less attention than it deserves. Retailers and platforms together are the part of the system that can change it.

Retail pharmacy and mass retail are on the front line of the consumer search for non opioid pain options. The bioelectric category is one of the categories meeting that demand.